Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Articles

Manja Boerman tapped as president of Cell & Gene Therapy for Catalent with retirement of Pete Buzy.

Catalent Announces Cell & Gene Therapy Leaders

Private equity firm, Ampersand Capital Partners, has made a majority investment into contract packaging organization (CPO), Tjoapack. 

Private Equity Firm Invests in Tjoapack

Wavelength Pharmaceuticals expanded production of APIs for certain pharmaceutical products needed to manage respiratory critical care patients in the COVID-19 pandemic.

Wavelength Pharmaceuticals Expands Supplies of Drug Ingredients for Managing COVID-19 and Adds API CDMO Services

Catalent Biologics increased capacity at its Bloomington, IN Facility.

Catalent Expands Biologics Packaging Capacity

The company will build an additional commercial-scale, contract manufacturing facility for viral vectors and gene therapies near its existing site in Carlsbad, CA.

MilliporeSigma Adds Viral Vector and Gene Therapy Capacity

The guidance document describes the agency’s temporary policy for the compounding of drugs during the COVID-19 pandemic. 

FDA Publishes Temporary Policy on Compounding of Drugs

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Civica Rx plans redundant manufacturing capacity to relieve and prevent shortages of generic, sterile injectable drugs. 

Addressing Drug Shortages

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Characterizing and controlling protein aggregation is vital to ensure safety and efficacy of a biopharmaceutical product. In this interview, important aspects of protein aggregation and the tools available to address this issue are discussed.


Keeping Aggregation Under Control

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

More sustainable and functional packaging protects temperature-sensitive drugs.

Packaging Preserves the Cold Chain

Considering the potential interaction of a drug with the delivery device early on in in development is integral to achieving the best combination.